Search Results - "Issa GC"

Case Report: FIA plus venetoclax in a patient on hemodialysis.

Authors: Herstein JE Marx KR Savoy JM et al.

Source: Frontiers in oncology [Front Oncol] 2026 Jan 15; Vol. 15, pp. 1740357. Date of Electronic Publication: 2026 Jan 15 (Print Publication: 2025).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Use of menin inhibitors for acute leukemia.

Authors: Issa GC; The University of Texas MD Anderson Cancer Center, Houston, Texas.

Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2026 Jan-Feb; Vol. 24 (1), pp. 37-39.

Publication Type: Interview

Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE; In Process

Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia.

Authors: Issa GC Larson RA Hughes TP et al.

Source: Haematologica [Haematologica] 2026 Jul 02. Date of Electronic Publication: 2026 Jul 02.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

Authors: Kadia TM Bataller A Bazinet A et al.

Source: American journal of hematology [Am J Hematol] 2026 Jul; Vol. 101 (7), pp. 1737-1747. Date of Electronic Publication: 2026 Apr 25.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Blinatumomab and Ponatinib Versus Hyper-CVAD and Ponatinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Propensity Score Analysis.

Authors: Sasaki K Kantarjian H Rausch CR et al.

Source: American journal of hematology [Am J Hematol] 2026 Jul; Vol. 101 (7), pp. 1717-1722. Date of Electronic Publication: 2026 Apr 24.

Publication Type: Letter

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process

Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid Neoplasms.

Authors: Khanlari M Wang W Thakral B et al.

Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2026 Jun 30; Vol. 39 (9), pp. 101032. Date of Electronic Publication: 2026 Jun 30.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study.

Authors: Short NJ Bataller A DiNardo CD et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27.

Publication Type: Journal Article

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

Authors: Nguyen D Kantarjian HM Bidikian A et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

Authors: Issa GC Cuglievan B El Hajjar G et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun 11, pp. JCO2601159. Date of Electronic Publication: 2026 Jun 11.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Authors: Fiskus W Mill CP Issa GC et al.

Source: Blood [Blood] 2026 Jun 04; Vol. 147 (23), pp. 2809-2820.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia.

Authors: Wang ES Erba HP Zeidan AM et al.

Source: Blood [Blood] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Authors: Loghavi S Farhat A Jamison TJ et al.

Source: Leukemia [Leukemia] 2026 Jun; Vol. 40 (6), pp. 1142-1150. Date of Electronic Publication: 2026 Mar 11.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

The role of advanced molecular diagnostics in informing targeted therapies for AML.

Authors: Marvin-Peek J Loghavi S Issa GC et al.

Source: Human pathology [Hum Pathol] 2026 May 30, pp. 106179. Date of Electronic Publication: 2026 May 30.

Publication Type: Journal Article; Review

Journal Info: Publisher: W B Saunders Country of Publication: United States NLM ID: 9421547 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8392 (Electronic) Linking ISSN: 00468177 NLM ISO Abbreviation: Hum Pathol Subsets: MEDLINE

Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

Authors: Short NJ Kantarjian HM Daver NG et al.

Source: Blood advances [Blood Adv] 2026 May 27. Date of Electronic Publication: 2026 May 27.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

Authors: Marvin-Peek J DiNardo CD Loghavi S et al.

Source: Cancer [Cancer] 2026 May 15; Vol. 132 (10), pp. e70434.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Authors: Montalban-Bravo G Wu C Rodriguez-Sevilla JJ et al.

Source: Blood cancer discovery [Blood Cancer Discov] 2026 May 05; Vol. 7 (3), pp. 414-430.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE

Menin and BCL2 inhibitors - shaken and stirred.

Authors: Bataller A Issa GC

Source: Haematologica [Haematologica] 2026 May 01; Vol. 111 (5), pp. 1513-1514. Date of Electronic Publication: 2026 Jan 22.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE; In Process

Outcomes of Patients Treated With Dasatinib 50 mg/d: A Pooled Analysis.

Authors: Haddad FG Jabbour E Sasaki K et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 May; Vol. 26 (5), pp. e678-e682.e1. Date of Electronic Publication: 2026 Mar 03.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Management of chronic myeloid leukemia in 2025.

Authors: Kantarjian H Breccia M Haddad FG et al.

Source: Cancer [Cancer] 2025 Jul 15; Vol. 131 (14), pp. e35953.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies.

Authors: Senapati J Loghavi S Marvin-Peek J et al.

Source: American journal of hematology [Am J Hematol] 2025 May; Vol. 100 (5), pp. 758-769. Date of Electronic Publication: 2025 Feb 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE